Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DCUN1D1 | Q96GG9 | 6/20 | 0.52 |
| ▸ | UBE2M | P61081 | 5/20 | 0.52 |
| ▸ | MEN1 | O00255 | 4/20 | 0.47 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.47 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.46 |
| ▸ | LMNA | P02545 | 2/20 | 0.45 |
| ▸ | HTT | P42858 | 2/20 | 0.45 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.45 |
| ▸ | USP2 | O75604 | 1/20 | 0.45 |
| ▸ | TSHR | P16473 | 1/20 | 0.45 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.45 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.45 |
| ▸ | MAPT | P10636 | 2/20 | 0.44 |
| ▸ | RECQL | P46063 | 1/20 | 0.44 |
| ▸ | ACKR3 | P25106 | 3/20 | 0.44 |
| ▸ | THRB | P10828 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31435224 | 0.91 | DCUN1D1 (0.53) | DCUN1D1UBE2MMEN1KMT2AALDH1A1 | |
| SCHEMBL31435238 | 0.89 | DCUN1D1 (0.56) | DCUN1D1UBE2MMEN1KMT2AALDH1A1 | |
| SCHEMBL31435226 | 0.89 | UBE2M (0.57) | DCUN1D1UBE2MMEN1KMT2AALDH1A1 | |
| SCHEMBL31435220 | 0.86 | UBE2M (0.60) | DCUN1D1UBE2MMEN1KMT2AALDH1A1 | |
| SCHEMBL31435259 | 0.81 | UBE2M (0.59) | DCUN1D1UBE2MMEN1KMT2AALDH1A1 | |
| SCHEMBL31435222 | 0.79 | UBE2M (0.46) | DCUN1D1UBE2MMEN1KMT2AALDH1A1 | |
| SCHEMBL31435231 | 0.79 | UBE2M (0.46) | DCUN1D1UBE2MMEN1KMT2AALDH1A1 | |
| SCHEMBL31435225 | 0.79 | UBE2M (0.46) | DCUN1D1UBE2MMEN1KMT2AALDH1A1 | |
| SCHEMBL31435237 | 0.79 | UBE2M (0.51) | DCUN1D1UBE2MMEN1KMT2AALDH1A1 | |
| SCHEMBL31435221 | 0.77 | UBE2M (0.50) | DCUN1D1UBE2MMEN1KMT2AALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025090928-A9 | COMPOUNDS FOR TREATMENT OF NEURODEGENERATIVE DISEASES | AQUINNAH PHARMACEUTICALS, INC. (US) | 2026-04-30 | — | — | WO | claimed |
| WO-2025090928-A1 | COMPOUNDS FOR TREATMENT OF NEURODEGENERATIVE DISEASES | AQUINNAH PHARMACEUTICALS, INC. (US) | 2025-05-01 | — | — | WO | claimed |
| WO-2025090928-A9 | COMPOUNDS FOR TREATMENT OF NEURODEGENERATIVE DISEASES | AQUINNAH PHARMACEUTICALS, INC. (US) | 2026-04-30 | — | — | WO | disclosed |
| WO-2025090928-A1 | COMPOUNDS FOR TREATMENT OF NEURODEGENERATIVE DISEASES | AQUINNAH PHARMACEUTICALS, INC. (US) | 2025-05-01 | — | — | WO | disclosed |